Skip to playerSkip to main content
  • 16 hours ago
A groundbreaking study in the US has revealed that artificial intelligence is capable of spotting pancreatic, lung, and colorectal cancers as much as four years ahead of human doctors recognizing any irregularities. The AI detected risk indicators in standard blood tests and imaging that were not visible to medical professionals. This research is currently undergoing FDA review, and numerous major healthcare systems in the US have initiated pilot programs.
Transcript
00:00A landmark study out of a major U.S. research institution has produced results
00:04that are reshaping how the medical community thinks about cancer detection.
00:08An artificial intelligence system trained on millions of medical records was able to identify
00:13early markers of certain cancers up to four years,
00:17before a human physician would have noticed anything abnormal.
00:20The study focused on pancreatic cancer, lung cancer, and colorectal cancer,
00:25three of the deadliest cancers in America,
00:28and found that AI analysis of routine blood tests, imaging,
00:32and patient records could flag risk patterns invisible to the human eye.
00:37Pancreatic cancer, which kills more than 50,000 Americans a year,
00:41has a survival rate above 40% when caught early, but drops to just 3% at stage 4.
00:47The potential impact of early AI detection on survival rates is enormous.
00:52The study is now being reviewed for FDA authorization.
00:55Several major U.S. health systems have already begun pilot programs.
01:00This may be the most consequential application of artificial intelligence in medicine in history.
Comments

Recommended